in order to stabilize the financial system. Nevertheless, as the COVID-19 situation has shown no clear sign of improvement and may persist throughout the first half of this year or beyond, pending the

evidenced, capital adequacy ratio (CAR) of KASIKORNBANK FINANCIAL CONGLOMERATE (the Conglomerate) according to the Basel III Accord was 18.32 percent, with a Tier 1 capital ratio of 15.90 percent. The

revenue from sale Baht 1,548.15 million, increased from last year Baht 5.73 million or 0.4%.  Gross profit increased from 43.6% to 44.4% of revenue from sale, as a result from improvement of inventory cost

of Baht 638.12 million, a 22.02% improvement year-over-year from Baht 522.98 million in 2017. This was mostly due to an increase in revenues from Inpatients, Outpatients and opening of IVF Center. The

year 2018 are Baht 127.9 million, an increase of Baht 68.5 million or 115%, mainly resulted from impairment loss from leasehold right of land and building improvement due following to the termination

from last year at 12.55% as the company implemented better production cost control for new products that could cause an improvement in production efficiency and could reduce loss in many as aspects. 3

reported Revenues from hospital operations of Thai Baht 886.04 million, a 38.85% improvement year-over-year from Baht 638.12 million in 2018. This was mostly due to an increase in revenues from Inpatients

% of net profit margin comparing with Q2 2016. Apart from the additional costs of SBT’s impairment, the increment of gross and net profit was mostly caused by the improvement of products’ spread margin

machines, as well as the decrease in production cost while there is no significant increase in other expenses. Overall, it resulted in the improvement of net profit margin for the group as mentioned. Please

MTHB or 4.8% of net profit margin comparing with Q3 2016. Apart from the additional costs of SBT’s liquidation, the increment of gross and net profit was mostly caused by the improvement of products